Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Finke

Showing results (151-160 of 180) with videos related to

Pageof 18
Sort By:
Blood Cancer Journal|March 12, 2021
CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomesEvandro D Bezerra, Terra L Lasho, Christy M Finke, et al.
Leukemia|June 10, 2020
Landscape of RAS pathway mutations in patients with myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a study of 461 molecularly annotated patientsAjinkya Buradkar, Evandro Bezerra, Giacomo Coltro, et al.
American Journal of Hematology|November 23, 2017
Driver mutations and prognosis in primary myelofibrosis: Mayo-Careggi MPN alliance study of 1,095 patientsAyalew Tefferi, Maura Nicolosi, Mythri Mudireddy, et al.
Leukemia|May 21, 2010
WHO-defined 'myelodysplastic syndrome with isolated del(5q)' in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutationsM M Patnaik, T L Lasho, C M Finke, et al.
Leukemia|April 15, 2018
GIPSS: genetically inspired prognostic scoring system for primary myelofibrosisAyalew Tefferi, Paola Guglielmelli, Maura Nicolosi, et al.
American Journal of Hematology|June 23, 2026
Extended Cancer Spectrum in Adults With Telomere Biology Disorders: Insights From a 113-Patient Single-Center CohortMadeline A Franke, Terra L Lasho, Christy M Finke, et al.
British Journal of Haematology|January 17, 2020
Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia veraAyalew Tefferi, Paola Guglielmelli, Terra L Lasho, et al.
Blood Advances|January 4, 2018
Targeted deep sequencing in polycythemia vera and essential thrombocythemiaAyalew Tefferi, Terra L Lasho, Paola Guglielmelli, et al.
American Journal of Hematology|April 10, 2019
Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patientsTucker Coston, Prateek Pophali, Rangit Vallapureddy, et al.
Leukemia|May 29, 2010
IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosisA Tefferi, T L Lasho, O Abdel-Wahab, et al.
Pageof 18

Showing results (151-160 of 180) with videos related to

Sort By:
Pageof 18
Blood Cancer Journal|March 12, 2021
CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomesEvandro D Bezerra, Terra L Lasho, Christy M Finke, et al.
Leukemia|June 10, 2020
Landscape of RAS pathway mutations in patients with myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a study of 461 molecularly annotated patientsAjinkya Buradkar, Evandro Bezerra, Giacomo Coltro, et al.
American Journal of Hematology|November 23, 2017
Driver mutations and prognosis in primary myelofibrosis: Mayo-Careggi MPN alliance study of 1,095 patientsAyalew Tefferi, Maura Nicolosi, Mythri Mudireddy, et al.
Leukemia|May 21, 2010
WHO-defined 'myelodysplastic syndrome with isolated del(5q)' in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutationsM M Patnaik, T L Lasho, C M Finke, et al.
Leukemia|April 15, 2018
GIPSS: genetically inspired prognostic scoring system for primary myelofibrosisAyalew Tefferi, Paola Guglielmelli, Maura Nicolosi, et al.
American Journal of Hematology|June 23, 2026
Extended Cancer Spectrum in Adults With Telomere Biology Disorders: Insights From a 113-Patient Single-Center CohortMadeline A Franke, Terra L Lasho, Christy M Finke, et al.
British Journal of Haematology|January 17, 2020
Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia veraAyalew Tefferi, Paola Guglielmelli, Terra L Lasho, et al.
Blood Advances|January 4, 2018
Targeted deep sequencing in polycythemia vera and essential thrombocythemiaAyalew Tefferi, Terra L Lasho, Paola Guglielmelli, et al.
American Journal of Hematology|April 10, 2019
Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patientsTucker Coston, Prateek Pophali, Rangit Vallapureddy, et al.
Leukemia|May 29, 2010
IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosisA Tefferi, T L Lasho, O Abdel-Wahab, et al.
Pageof 18